Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma (OAIE)

计划入组 81 人 · 首次发布于 2022 年 3 月 14 日

Toripalimab Combined With CAV/IE Regimen

计划入组 134 人 · 首次发布于 2020 年 10 月 19 日

Effect of IE Glasses on MRI Patient Outcomes

计划入组 300 人 · 首次发布于 2026 年 6 月 22 日

D5D inhibitors(Takeda Pharmaceutical Company Limited)

Uniflu vaccine (VA Pharma Limited Liability Company)

Seasonal Influenza Vaccine(China National Biotec Group Company Limited)

PERRIGO COMPANY PUBLIC LIMITED COMPANY

Ireland

ACCENTURE PUBLIC LIMITED COMPANY

Ireland

PTT PUBLIC COMPANY LIMITED

Thailand

Xtrackers MSCI World Biotechnology UCITS ETF Shows Strong Bullish Signals Across All Time Horizons

Hansoh Pharma's HS-20093 Granted Breakthrough Therapy Designation for Lung Cancer

Hansoh Pharma's Aumolertinib Plus Chemotherapy Shows Positive Phase III Results in EGFR-Mutated NSCLC